Examining issues related to competition in the pharmaceutical marketplace :  a review of the FTC report, generic drug entry prior to patent expiration : hearing before ... 107th Congress, 2nd session, October 9, 2002. 
 Generic drug entry prior to patent expiration 

 - Washington, DC :  U.S. G.P.O.,  2002. 
 - iii, 142 pages ;  24 cm 
<br/><br/> "Serial no. 107-140."  Shipping list no.:2003-0144-M.  CRDP Program record. 
<br/><br/>Includes bibliographical references. 
<br/><br/><br/>Microfiche. <br/>Washington : <br/>Supt. of Docs., U.S. G.P.O., <br/>2003. <br/>2 microfiches : negative. 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Generic drugs.<br/>Competition.<br/>Pharmaceutical industry.
<br/><br/><label>GPO Item No.: </label>1019-B-01 (MF) 
<br/><br/><label>Gov. Doc. Class. No.: </label>Y 4.C 73/8:107-140